Characterizing the burden of hepatitis c infection among entrants to Pennsylvania state prisons, 2004 to 2012

Journal of Correctional Health Care

Volumn 22, Issue 1, 2016, Pages 41-45

  Mahowald, Madeline K ^a   Larney, Sarah ^b   Zaller, Nickolas D ^c   Scharff, Nicholas ^d   Taylor, Lynn E ^e   Beckwith, Curt G ^e   Noska, Amanda ^e   Rich, Josiah D ^e   Flanigan, Timothy P ^e  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Michigan Department of Corrections   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Chronic hepatitis C infection; Correctional health; Hepatitis C genotype distribution; Prevalence

Indexed keywords

HEPATITIS B ANTIBODY;

ADULT; BLOOD; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C, CHRONIC; HUMAN; MALE; MASS SCREENING; PENNSYLVANIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRISON; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; FEMALE; GENOTYPE; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MALE; MASS SCREENING; PENNSYLVANIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRISONS; RISK FACTORS;

EID: 84960467722     PISSN: 10783458     EISSN: 19405200     Source Type: Journal    
DOI: 10.1177/1078345815618384     Document Type: Article

References (12)

1. Allen, S. A., Spaulding, A. C., Osei, A. M., Taylor, L. E., Cabral, A. M., & Rich, J. D. (2003). Treatment of chronic hepatitis C in a state correctional facility. Annals of Internal Medicine, 138, 187–190.
2. Chew, K. W., Allen, S. A., Taylor, L. E., Rich, J. D., & Feller, E. (2009). Treatment outcomes with PEGylated interferon and ribavirin for male prisoners with chronic hepatitis C. Journal of Clinical Gastroenterology, 43, 686–691. doi:10.1097/MCG.0b013e31818dd94c
3. Ditah, I., Ditah, F., Devaki, P., Ewelukwa, O., Ditah, C., Njei, B., Charlton, M. (2014). The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. Journal of Hepatology, 60, 691–698. doi:10.1016/j.jhep.2013.11.014
4. Glaze, L. E., & Parks, E. (2012). Correctional populations in the United States, 2011 (NCJ 239972). Washington, DC: Bureau of Justice Statistics. Retrieved from http://www.bjs.gov/index.cfm?ty¼pbdetail&iid¼4537
5. Kowdley, K. V., Lawitz, E., Poordad, F., Cohen, D. E., Nelson, D. R., Zeuzem, S., Bernstein, B. (2014). Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1. New England Journal of Medicine, 370, 222–232. doi:10.1056/NEJMoa1306227
6. Larney, S., Kopinski, H., Beckwith, C. G., Zaller, N. D., Jarlais, D. D., Hagan, H., Degenhardt, L. (2013). The incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis. Hepatology, 58, 1215–1224. doi:10.1002/hep.26387
7. Larney, S., Mahowald, M. K., Scharff, N., Flanigan, T. P., Beckwith, C. G., & Zaller, N. D. (2014). Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: Limitations of 1945-1965 birth cohort screening in correctional settings. American Journal of Public Health, 104, e69–e74. doi:10.2105/ajph.2014.301943
8. Liang, T. J., & Ghany, M. G. (2013). Current and future therapies for hepatitis C virus infection. New England Journal of Medicine, 368, 1907–1917. doi:10.1056/NEJMra1213651
9. Martin, N. K., Hickman, M., Hutchinson, S. J., Goldberg, D. J., & Vickerman, P. (2013). Combination interventions to prevent HCV transmission among people who inject drugs: Modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clinical Infectious Diseases, 57,S39–S45. doi:10.1093/cid/cit296
10. Meyer, M. F., Wedemeyer, H., Monazahian, M., Dreesman, J., Manns, M. P., & Lehmann, M. (2007). Prevalence of hepatitis C in a German prison for young men in relation to country of birth. Epidemiology and Infection, 135, 274–280. doi:10.1017/s0950268806006820
11. Mustard, D. (2001). Racial, ethnic, and gender disparities in sentencing: Evidence from the U.S. federal courts. Journal of Law and Economics, 44, 285–314. doi:10.1086/320276
12. Varan, A. K., Mercer, D. W., Stein, M. S., & Spaulding, A. C. (2014). Hepatitis C seroprevalence among prison inmates since 2001: Still high but declining. Public Health Reports, 129, 187–195.